Greece: Tricky issues on dual jurisdiction

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greece: Tricky issues on dual jurisdiction

According to the Greek Law on Trade Marks, civil courts have jurisdiction to rule in trade mark infringement cases, whereas administrative courts have jurisdiction on a trade mark's registrability.

A leading company in the field of consumer goods is the owner of various trade marks in Greece consisting of the term "ΧΛΩΡΙΝΗ" and/or its English transliteration "Klorin" for goods in class 3, namely cleansers for household purposes. This mark has a long history of extensive use in the Greek market since the early 1960s by either its current owner or its predecessors.

In fact, it has become so known and established that the relevant public has been using it in order to define a cleanser consisting of a sodium hypochlorite solution. What's next? Another leading company in the same field of business filed a trade mark consisting of that term along with a mark, which is also a well-known trade mark in the competitor's name among the Greek public.

The first company commenced trade mark infringement proceedings before the civil courts and the second commenced invalidity proceedings before the Trademarks Administrative Commission, which by law follow the route of the administrative court's jurisdiction on appeal. In both instances the underlying question is whether Klorin is a well-known trade mark or a trade mark that has become of common use. The Supreme Court, which is the highest level judicial authority in civil proceedings has definitively ruled that the TM owner's competitor has not infringed the TM, since it has been used to define the kind of the product concerned. Alas, the Administrative Court is not of the same view: so far, that is to say before the Administrative Court of Appeal, it was held that Klorin is a well-known mark. As a matter of procedure, the losing party has the right to file a revocation petition before the Council of State, which is the highest level judicial authority in administrative proceedings.

What will happen if the Council of State affirms the trade mark's well-known status, which is contrary to the ruling of the Supreme Court? It seems that in addition to business competition, judicial competition has a role to play in this case.

Manolis Metaxakis


Patrinos & Kilimiris7, Hatziyianni Mexi Str.GR-11528 AthensGreeceTel: +30210 7222906, 7222050Fax: +30210 7222889info@patrinoskilimiris.comwww.patrinoskilimiris.com

more from across site and SHARED ros bottom lb

More from across our site

Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Gift this article